MYBPC3 non-truncating variants in HCM cohorts


The table below lists the 338 rare (MAF<0.0001 in ExAC) non-truncating MYBPC3 variants identified in a cohort of 3267 HCM patients. When this rare variant frequency of 0.10346 is compared with a background population rate of 0.01884, there is a statistically significant case excess of 0.08462 (p<0.0001), which suggests that approximately 277 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (3267)OMGL class ExAC frequency
1. c.3373G>A p.V1125Mmissense 1VUS0.000022
2. c.2573G>A p.S858Nmissense 2Likely Pathogenic0.000000
3. c.3614G>A p.R1205Qmissense 1VUS0.000016
4. c.2249C>T p.T750Mmissense 1Likely Pathogenic0.000024
5. c.1828G>C p.D610Hmissense 1VUS0.000058
6. c.1789C>T p.R597Wmissense 1VUS0.000038
7. c.1456T>G p.W486Gmissense 1VUS0.000000
8. c.1505G>A p.R502Qmissense 2Pathogenic0.000000
9. c.1123G>A p.V375Mmissense 3VUS0.000009
10. c.1021G>A p.G341Smissense 1VUS0.000025
11. c.532G>A p.V178Mmissense 1VUS0.000020
12. c.1213A>G p.M405Vmissense 1VUS0.000000
13. c.710A>C p.Y237Smissense 3Likely Pathogenic0.000000
14. c.3739G>A p.D1247Nmissense 1VUS0.000000
15. c.1886T>C p.L629Pmissense 2VUS0.000000
16. c.3206C>A p.P1069Hmissense 1Likely Pathogenic0.000000
17. c.2381C>A p.P794Qmissense 1VUS0.000000
18. c.1A>T p.Met1?missense 1Likely Pathogenic0.000000
19. c.1174G>T p.A392Smissense 1VUS0.000000
20. c.3676C>T p.R1226Cmissense 1VUS0.000058
21. c.3019T>C p.W1007Rmissense 1VUS0.000000
22. c.3452C>T p.A1151Vmissense 1VUS0.000078
23. c.2459G>A p.R820Qmissense 5VUS0.000016
24. c.2873C>T p.T958Imissense 1VUS0.000065
25. c.2269G>A p.V757Mmissense 1VUS0.000066
26. c.3065G>C p.R1022Pmissense 5Likely Pathogenic0.000025
27. c.1624G>C p.E542Qmissense 24Pathogenic0.000024
28. c.2308G>A p.D770Nmissense 5Likely Pathogenic0.000008
29. c.1471G>A p.V491Mmissense 1VUS0.000058
30. c.2197C>T p.R733Cmissense 1Likely Pathogenic0.000085
31. c.1291G>A p.D431Nmissense 1VUS0.000028
32. c.799C>G p.L267Vmissense 1VUS0.000080
33. c.1483C>T p.R495Wmissense 2Likely Pathogenic0.000000
34. c.1037G>A p.R346Hmissense 1VUS0.000000
35. c.188G>A p.R63Qmissense 1VUS0.000039
36. c.3752A>G p.Y1251Cmissense 2VUS0.000000
37. c.844C>T p.R282Wmissense 1Likely Pathogenic0.000000
38. c.1455A>T p.K485Nmissense 1VUS0.000000
39. c.2834G>A p.R945Qmissense 1VUS0.000000
40. c.3572C>T p.S1191Lmissense 1VUS0.000016
41. c.701C>A p.T234Nmissense 1Likely Pathogenic0.000000
42. c.3713T>C p.L1238Pmissense 1Likely Pathogenic0.000000
43. c.3316G>A p.D1106Nmissense 1VUS0.000061
44. c.2504G>T p.R835Lmissense 1Likely Pathogenic0.000074
45. c.3613C>T p.R1205Wmissense 10Likely Pathogenic0.000016
46. c.1828G>A p.D610Nmissense 2VUS0.000000
47. c.2210C>T p.T737Mmissense 3VUS0.000050
48. c.1720C>T p.R574Wmissense 3VUS0.000054
49. c.2432A>G p.K811Rmissense 2VUS0.000000
50. c.1112C>T p.P371Lmissense 1VUS0.000028
51. c.1433C>T p.S478Lmissense 1Likely Pathogenic0.000017
52. c.1504C>T p.R502Wmissense 59Pathogenic0.000024
53. c.49C>T p.R17Wmissense 1VUS0.000023
54. c.994G>A p.E332Kmissense 1VUS0.000009
55. c.442G>A p.G148Rmissense 4Likely Pathogenic0.000042
56. c.1153G>A p.V385Mmissense 1VUS0.000010
57. c.655G>C p.V219Lmissense 18Likely Pathogenic0.000000
58. c.2968C>G p.P990Amissense 1Likely Pathogenic0.000000
59. c.3728C>G p.P1243Rmissense 1VUS0.000000
60. c.1756C>G p.P586Amissense 1Likely Pathogenic0.000000
61. c.3771C>A p.N1257Kmissense 9Likely Pathogenic0.000000
62. c.2219G>C p.G740Amissense 2VUS0.000000
63. c.1097A>C p.Q366Pmissense 1VUS0.000000
64. c.3656T>C p.L1219Pmissense 1VUS0.000000
65. c.3005G>A p.R1002Qmissense 2VUS0.000046
66. c.2265C>A p.N755Kmissense 1Pathogenic0.000000
67. c.3064C>T p.R1022Cmissense 1VUS0.000008
68. c.2449C>T p.R817Wmissense 1VUS0.000000
69. c.1841A>G p.Y614Cmissense 1VUS0.000000
70. c.2030C>T p.P677Lmissense 1VUS0.000000
71. c.1591G>A p.G531Rmissense 1Likely Pathogenic0.000017
72. c.1790G>A p.R597Qmissense 1VUS0.000000
73. c.557C>T p.P186Lmissense 2VUS0.000047
74. c.772G>A p.E258Kmissense 47Pathogenic0.000039
75. c.1483C>G p.R495Gmissense 10Likely Pathogenic0.000000
76. c.1021G>C p.G341Rmissense 1VUS0.000000
77. c.187C>T p.R63Wmissense 1VUS0.000077
78. c.3256T>C p.W1086Rmissense 1VUS0.000000
79. c.631G>A p.D211Nmissense 1VUS0.000009
80. c.3751T>C p.Y1251Hmissense 2VUS0.000000
81. c.241G>T p.V81Fmissense 1VUS0.000000
82. c.3364A>T p.T1122Smissense 1Likely Pathogenic0.000000
83. c.1231A>G p.I411Vmissense 1VUS0.000000
84. c.2708G>A p.G903Dmissense 1Likely Pathogenic0.000000
85. c.3470C>T p.P1157Lmissense 2VUS0.000093
86. c.2909G>A p.R970Qmissense 1Likely Pathogenic0.000032
87. c.2300A>G p.K767Rmissense 2VUS0.000016
88. c.3277G>T p.G1093Cmissense 3VUS0.000020
89. c.2503C>T p.R835Cmissense 1VUS0.000024
90. c.2429G>A p.R810Hmissense 11VUS0.000033
91. c.2198G>A p.R733Hmissense 1VUS0.000034
92. c.1685C>T p.A562Vmissense 1VUS0.000008
93. c.818G>A p.R273Hmissense 2VUS0.000042
94. c.1484G>A p.R495Qmissense 4Likely Pathogenic0.000008
95. c.1072G>A p.D358Nmissense 1VUS0.000008
96. c.3798C>G p.C1266Wmissense 4VUS0.000000
97. c.373G>T p.A125Smissense 1VUS0.000000
98. c.148A>G p.S50Gmissense 1VUS0.000038
99. c.2953A>G p.K985Emissense 1Pathogenic0.000000
100. c.365C>A p.A122Dmissense 1VUS0.000000
101. c.3614G>C p.R1205Pmissense 1Likely Pathogenic0.000000
102. c.1731G>C p.W577Cmissense 1VUS0.000000
103. c.1080G>C p.K360Nmissense 1VUS0.000000
104. c.3763G>A p.A1255Tmissense 3VUS0.000075
105. c.3334_3351del p.Trp1112_Glu1117delinframe 1Likely Pathogenic0.000000
106. c.256_258del p.Ser86delinframe 1VUS0.000000
107. c.3455_3466del p.Ala1152_Lys1155delinframe 2Likely Pathogenic0.000000
108. c.146_148delTCA p.Ile49delinframe 1VUS0.000039
109. c.3582_3593delGGGCTACACTGC inframe 2Likely Pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.